Subscribe
type here...
Subscribe

Innovation

OpenAI Enters Healthcare Market with ChatGPT Health and Enterprise Clinical Platform

AI in Pharma Techno -
OpenAI has officially announced its expansion into the healthcare sector with the launch of a dedicated product line. The company introduced the consumer-facing ChatGPT...

FEFU to Launch Russia’s First University-Based GMP Site for Biologics

Drug Development Techno -
Far Eastern Federal University (FEFU) has announced plans to establish a comprehensive infrastructure for the development and commercialization of biotech products.
spot_imgspot_img

FMBA Files for Registration of “Allergarda,” a Recombinant Vaccine for Birch Pollen Allergy

Approvals Techno -
The vaccine is currently in Phase III clinical trials, evaluating its efficacy against a placebo in patients with allergic rhinitis.

Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia

Drug Development Techno -
Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia from September...

Sanofi-GSK’s Covid vaccine, effective against omicron, could hit the market this year

Global Markets Techno -
Sanofi and GSK today announce positive data from their vaccine trial which evaluated an adjuvanted bivalent D614 and Beta...

OSE Immunotherapeutics collaborates with Microsoft to further develop its digital infrastructures

AI in Pharma Techno -
OSE Immunotherapeutics SA today announces that the Company is one of the first biotech startup companies selected by Microsoft...

Rune Labs gets FDA approval to use Apple Watch to track Parkinson’s disease symptoms

Approvals Techno -
San Francisco-based startup Rune Labs on Monday said it received clearance from the U.S. Food and Drug Administration to...

FDA approves Lilly and Incyte’s Olumiant® for alopecia areata

Global Markets Techno -
Eli Lilly and Company and Incyte announced  that the U.S. Food and Drug Administration (FDA) has approved OLUMIANT® (baricitinib),...
Load more

PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).

Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.

Company

Headlines

Obesity Pill Battle: Lilly’s Chemistry vs. Novo’s Peptides

0
2026 marks not just the arrival of new therapies,...

OpenAI Enters Healthcare Market with ChatGPT Health and Enterprise Clinical Platform

0
OpenAI has officially announced its expansion into the healthcare...

FEFU to Launch Russia’s First University-Based GMP Site for Biologics

0
Far Eastern Federal University (FEFU) has announced plans to establish a comprehensive infrastructure for the development and commercialization of biotech products.

FMBA Files for Registration of “Allergarda,” a Recombinant Vaccine for Birch Pollen Allergy

0
The vaccine is currently in Phase III clinical trials, evaluating its efficacy against a placebo in patients with allergic rhinitis.

Newsletter

Get important news delivered directly to your inbox and stay connected!

© PHARMPROM 2026